- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07294443
Qigong Relaxation Exercise (QRE)
The Effect of Qigong Relaxation Exercise on Anxiety and Depression Levels in Individuals Diagnosed With Depression Hospitalized in a Psychiatric Clinic
Objective: This study was conducted to examine the effect of Qigong relaxation exercises applied in a psychiatric clinic on the anxiety and depression levels of patients diagnosed with depression.
Design: This study was designed as a single-blind, randomized controlled trial. Research Hypotheses H1: State anxiety levels are lower in patients who perform Qigong exercises than in those who do not.
H2: Depression levels are lower in patients who perform Qigong exercises than in those who do not.
The study population consisted of 140 individuals aged 18 years and older diagnosed with depression who were hospitalized at a private psychiatric hospital in Turkey between March 1 and September 1, 2025. In the sample selection, the STAI-I and Beck Depression Scale were administered to the patients by the researchers. Since differences in anxiety and depression levels would affect group homogeneity, patients who scored below 35 on the STAI-I (mild and moderate levels) and between 17 and 30 on the Beck Depression Scale constituted the study sample. The study sample consisted of 70 patients.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Üsküdar - Selimiye
-
Istanbul, Üsküdar - Selimiye, Turkey (Türkiye), 34668
- Health Sciences University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The patient is literate
- No communication barriers
- The patient is receiving inpatient treatment at a psychiatric clinic
- The patient has been diagnosed with depression
- The patient is over 18 years of age
- The patient is oriented to the service (at least 24 hours have passed since admission)
- The patient regularly participates in Qigong practice
Exclusion Criteria:
- The patient has communication difficulties
- The patient has acute psychotic symptoms
- The patient is receiving anxiolytic treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control group
|
The control group's ongoing treatment continued.
|
|
Experimental: QRE
|
Qigong relaxation exercise is a type of exercise consisting of graceful body movements and relaxation, performed in harmony with breathing and meditation, aimed at relaxing the body and mind, reducing stress, diverting attention away from negative thoughts, accelerating blood flow, and improving emotions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Scale
Time Frame: 6 weeks
|
Beck Depression Scale: The Beck Depression Scale was used to measure the level and severity of depressive symptoms.
The Beck Depression Scale, which underwent a Turkish validity and reliability study by Hisli in 1988, is a depression rating scale consisting of 21 questions.
Individuals mark the statement that best describes how they have felt over the past 15 days, and the total score is calculated by summing the points (0-3) obtained from each response.
According to the corresponding score ranges, the scale is evaluated as follows: 1-10 is normal, 11-16 is moderate mood disorder, 17-20 is clinical depression, 21-30 is moderate depression, 31-40 is severe depression, and 41-63 is major depression.
|
6 weeks
|
|
State-Trait Anxiety Inventory
Time Frame: 6 weeks
|
This scale was developed by Spielberger et al. (1983), and its validity and reliability in Turkish were established by Öner and Le Compte (1985).
The scale consists of two parts: the State Anxiety Scale (STAI-I) and the Trait Anxiety Scale (STAI-II).
STAI-I examines how an individual feels at a specific time and under specific conditions, while STAI-II determines how an individual feels independently of the situation and conditions they are in.
STAI-I form, which consists of 20 statements, was used to measure state anxiety.
Respondents rated their level of anxiety on a 4-point (1- 4) intensity scale from not at all tovery much so.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 61351342
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Qigong relaxation exercises
-
Biruni UniversityCompletedSedentary Behavior | Health BehaviorTurkey
-
Akdeniz UniversityCompletedQuality of Life | Postoperative Pain | Muscle Weakness | Pain, Shoulder | Respiratory Function Loss | Joint AdhesionTurkey
-
National Center for Complementary and Integrative...Completed
-
University of MinnesotaRecruiting
-
Cairo UniversityCompletedQuality of Life | Sleep Quality | Functional Capacity | Motor Function | Ventilatory FunctionEgypt
-
Ataturk UniversityCompletedStress | Anxiety | Nursing Students | Relaxation ProgramTurkey
-
Istanbul University - Cerrahpasa (IUC)Recruiting
-
Istanbul University - Cerrahpasa (IUC)Enrolling by invitationAnxiety LevelTurkey
-
Northeast Normal UniversityCompleted
-
Osmaniye Korkut Ata UniversityCompleted